News

Quick Hits: Cannabis news in brief

Published on April 10, 2026 by Pat Bulmer

Photo: Contributed

Cannabis news in brief: Pink Goo goes East; StigmaGrow financials delayed; High Tide wants into hemp pilot; Canopy launches Deelish; Hybrida Farms competes internationally; Should 420 be a holiday?; Cannabix breathalyzer sold; Organigram buys Sanity Group; CBD still unaccepted; Better Terms for Village Farms 

Pink Goo coming to Nova Scotia

Nova Scotia is about to get some Pink Goo.

The flower brand from BC’s Pistol and Paris will arrive in the eastern province on May 4 in a 3.5-gram container.

Pink Goo is described as a BC classic that pre-dates legalization.

“Pink Goo isn’t easy to grow. The resin is heavy, the plant is demanding, and cutting corners shows,” the company said in a news release. “Sticky, sedative, and unmistakably Kush-forward, Pink Goo has been one of Canada’s most sought-after strains since long before a single dispensary opened its doors. Visually, it makes an impression: dense, resinous buds (and) pink and purple colouring.”

Financial update delayed

Calgary-based CanadaBis Capital (aka StigmaGrow) has announced a delay in putting out its latest financial report.

Instead of declaring “We’re making so much money, we need more time to count it all,” the company’s explanation was less inspiring: “The delay in filing the interim filings is attributable to the company’s current resource constraints and its ongoing efforts to manage its financial position and reporting processes.”

The report for the quarter ending Jan. 31 was to be filed by March 31.

“Further updates will be provided as they become available,” a news release said.

High Tide hopes to get in on US program

A Canadian cannabis company’s US subsidiary is hoping to participate in a government pilot program to distribute hemp-derived CBD products.

The project, which has just launched, will supply eligible products to Medicare beneficiaries, up to US$500 worth per person per year.

NuLeaf Naturals, founded in 2014 in Denver, is applying to join the program.

“NuLeaf’s product portfolio includes THC-free and broad-spectrum CBD formats designed to align with the pilot program’s compliance requirements,” Calgary-based High Tide said in a news release.

“The launch of the CMS (Centers for Medicare and Medicaid Services) pilot program is a historic moment for the U.S. CBD industry,” said High Tide CEO Raj Grover.

In December, U.S. President Donald Trump signed an executive order encouraging CBD products to be tested in trial programs. This program will allow Medicare beneficiaries to receive CBD products if recommended by their physicians.

Canopy’s new brand is Deelish

Canopy Growth has a new cannabis brand.

“Deelish enters the market built to deliver high THC with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC,” the company said.

Four Deelish offerings will go on the shelves in Ontario and Alberta:

— Pretty Sweet Sativa 28g Whole Flower – 27-33% THC

— Pretty Sweet Sativa 2x1g Pre-roll Joints – 26-32% THC

— Pretty Chill Indica 28g Whole Flower – 27-33% THC

— Pretty Chill Indica 2x1g Pre-roll Joints – 26-32% THC.

The lineup will rotate regularly, the company said. The brand is intended to be at the lower end of the price scale.

New competitor in export market

Canadian companies have more competition in the cannabis export market.

Costa Rica’s first cannabis export to the European Union was made last month.

Hybrida Farms, the brand name for Vantage Point Global CR S.A., has exported “pharmaceutical-grade” medical cannabis.

“Hybrida Farms is Costa Rica’s first and only dual licensed operator authorized for both THC medical cannabis and industrial hemp,” the company said in a news release.

The company converted an old tomato-growing site to grow cannabis.

“This milestone reflects what is possible when a country creates a legal pathway and operators commit to executing at the highest international standards. Costa Rica now has the opportunity to support and scale an industry,” the company proclaimed.

420 should be a holiday

A US cannabis retail chain is giving employees a holiday for 420.

Ethos Cannabis “will shut its doors on the industry’s biggest sales day, replacing a one-day discount event with a month-long campaign built around physician-led education, employee appreciation, and the original spirit of 420,” the company said.

“What began as a celebration of the plant is closer today to a retail frenzy, with discounts and doorbusters driving the conversation instead of intention and care,” said company CEO Gibran Washington. “This year, we’re reclaiming 420 for what it was always meant to be, a genuine celebration of the plant, the people who love it and the patients whose lives it changes.”

Retail locations across Pennsylvania, Massachusetts and Ohio will be closed on April 20.

The company will launch the month-long “More Than A Day” campaign, featuring commentary from Dr. William McLay, Ethos’ lead pharmacist.

Virginia company buys breathalyzers

A manufacturer in Virginia has bought cannabis breathalyzers from Vancouver’s Cannabix Technologies.

“The client, which operates large‑scale custom machinery fabrication, sought a scientifically grounded method to assess recent cannabis use among its workforce amid growing concerns about THC‑related safety incidents and the limitations of traditional drug testing,” Cannabix said in a news release.

The delivery was completed through an authorized reseller.

Cannabix developed the breathalyzer with U.S.-based Omega Labs. It was recently cleared for full-fledged sales.

“Our early delivery of the MBT (marijuana breath test) system to a major manufacturing client in Virginia demonstrates the growing interest for accurate, non‑invasive testing that focuses specifically on recent cannabis use,” said Cannabix CEO Rav Mlait.

Shareholders approve German purchase

Organigram shareholders have approved the purchase of Germany’s Sanity Group and the sale of shares to a wholly-owned subsidiary of British American Tobacco.

With the purchase, Organigram “will become a top company in the rapidly growing German medical cannabis market, the second largest federally legal cannabis market in the world after Canada,” the company said in a news release.

Sanity is also part of pilot project in Switzerland where it operates two legal cannabis stores.

Earlier, Organigram said it will pay €113.4 million to buy the shares it doesn’t yet own in Sanity Group GmbH. The deal still has some routine hurdles to overcome before it’s done.

The sale of $65 million worth of shares to BAT will help fund the purchase. BAT will have just under 30% control of Organigram.

The meeting on March 30 also elected a 10-person slate to the board of directors.

Organigram is one of Canada’s largest cannabis producers with operations in New Brunswick, Quebec, Ontario and Manitoba. Its brands include Big Bag O’ Buds, Shred, Tremblant, Collective Project, Trailblazer and Boxhot.

Village Farms gets better terms

Cannabis producer Village Farms has improved the terms of one of its loans.

The interest rate has been reduced and term extended on a loan with Farm Credit Canada.

“The FCC loan carries a variable interest rate currently below 7.0%, with a current balance of US$15.4 million,” Village Farms said in a news release. The maturity date was extended by four years to Feb. 3, 2031.

A month ago, Village Farms announced it had rearranged other Canadian loans.

“We remain in a very strong net cash position,” said CEO Michael DeGiglio then.

Village Farms operates production facilities in Delta, BC, and owns other Canadian operations. It also has operations in the US and Netherlands.